Royal Bank of Canada’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $130K | Buy |
19,342
+11,034
| +133% | +$74.2K | ﹤0.01% | 5122 |
|
|
2025
Q1 | $75K | Sell |
8,308
-3,491
| -30% | -$31.5K | ﹤0.01% | 5030 |
|
|
2024
Q4 | $204K | Sell |
11,799
-3,401
| -22% | -$58.8K | ﹤0.01% | 4353 |
|
|
2024
Q3 | $243K | Buy |
15,200
+6,778
| +80% | +$108K | ﹤0.01% | 4232 |
|
|
2024
Q2 | $120K | Buy |
8,422
+7,278
| +636% | +$104K | ﹤0.01% | 4773 |
|
|
2024
Q1 | $16K | Sell |
1,144
-5,941
| -84% | -$83.1K | ﹤0.01% | 5574 |
|
|
2023
Q4 | $107K | Buy |
7,085
+3,361
| +90% | +$50.8K | ﹤0.01% | 5054 |
|
|
2023
Q3 | $59K | Buy |
3,724
+1,491
| +67% | +$23.6K | ﹤0.01% | 5216 |
|
|
2023
Q2 | $34K | Buy |
+2,233
| New | +$34K | ﹤0.01% | 5507 |
|
|
2023
Q1 | – | Sell |
-28
| Closed | – | – | 6939 |
|
|
2022
Q4 | $0 | Buy |
+28
| New | – | ﹤0.01% | 7158 |
|
|
2022
Q2 | – | Sell |
-646
| Closed | -$6K | – | 7141 |
|
|
2022
Q1 | $6K | Sell |
646
-1,217
| -65% | -$11.3K | ﹤0.01% | 6712 |
|
|
2021
Q4 | $32K | Buy |
+1,863
| New | +$32K | ﹤0.01% | 6065 |
|